UniProt ID | DEFI6_HUMAN | |
---|---|---|
UniProt AC | Q9H4E7 | |
Protein Name | Differentially expressed in FDCP 6 homolog | |
Gene Name | DEF6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 631 | |
Subcellular Localization | Cytoplasm . Cell membrane . Nucleus . Cytoplasm, cytoskeleton . Cytoplasm, perinuclear region . Cell projection, filopodium . Recruited to the plasma membrane upon binding phosphatidylinositol 3,4,5-trisphosphate (PubMed:15023524). Binds to actin fil | |
Protein Description | Phosphatidylinositol 3,4,5-trisphosphate-dependent guanine nucleotide exchange factor (GEF) which plays a role in the activation of Rho GTPases RAC1, RhoA and CDC42. Can regulate cell morphology in cooperation with activated RAC1. Plays a role in Th2 (T helper cells) development and/or activation, perhaps by interfering with ZAP70 signaling (By similarity).. | |
Protein Sequence | MALRKELLKSIWYAFTALDVEKSGKVSKSQLKVLSHNLYTVLHIPHDPVALEEHFRDDDDGPVSSQGYMPYLNKYILDKVEEGAFVKEHFDELCWTLTAKKNYRADSNGNSMLSNQDAFRLWCLFNFLSEDKYPLIMVPDEVEYLLKKVLSSMSLEVSLGELEELLAQEAQVAQTTGGLSVWQFLELFNSGRCLRGVGRDTLSMAIHEVYQELIQDVLKQGYLWKRGHLRRNWAERWFQLQPSCLCYFGSEECKEKRGIIPLDAHCCVEVLPDRDGKRCMFCVKTANRTYEMSASDTRQRQEWTAAIQMAIRLQAEGKTSLHKDLKQKRREQREQRERRRAAKEEELLRLQQLQEEKERKLQELELLQEAQRQAERLLQEEEERRRSQHRELQQALEGQLREAEQARASMQAEMELKEEEAARQRQRIKELEEMQQRLQEALQLEVKARRDEESVRIAQTRLLEEEEEKLKQLMQLKEEQERYIERAQQEKEELQQEMAQQSRSLQQAQQQLEEVRQNRQRADEDVEAAQRKLRQASTNVKHWNVQMNRLMHPIEPGDKRPVTSSSFSGFQPPLLAHRDSSLKRLTRWGSQGNRTPSPNSNEQQKSLNGGDEAPAPASTPQEDKLDPAPEN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
27 | Phosphorylation | VEKSGKVSKSQLKVL HHHCCCCCHHHHHHH | 30.03 | 24275569 | |
28 | Ubiquitination | EKSGKVSKSQLKVLS HHCCCCCHHHHHHHH | 45.25 | - | |
79 | Ubiquitination | LNKYILDKVEEGAFV HHHHHHHHHHCCCCH | 48.37 | 29967540 | |
87 | Ubiquitination | VEEGAFVKEHFDELC HHCCCCHHHHHHHHH | 38.73 | 29967540 | |
100 | Ubiquitination | LCWTLTAKKNYRADS HHHEEECCCCCCCCC | 35.99 | 29967540 | |
107 | Phosphorylation | KKNYRADSNGNSMLS CCCCCCCCCCCCCCC | 45.73 | 22210691 | |
111 | Phosphorylation | RADSNGNSMLSNQDA CCCCCCCCCCCHHHH | 23.62 | 22210691 | |
144 | Phosphorylation | MVPDEVEYLLKKVLS ECCHHHHHHHHHHHH | 23.62 | 22817900 | |
151 | Phosphorylation | YLLKKVLSSMSLEVS HHHHHHHHHCCCEEE | 27.29 | 26074081 | |
152 | Phosphorylation | LLKKVLSSMSLEVSL HHHHHHHHCCCEEEH | 14.29 | 26074081 | |
154 | Phosphorylation | KKVLSSMSLEVSLGE HHHHHHCCCEEEHHH | 24.27 | 26074081 | |
158 | Phosphorylation | SSMSLEVSLGELEEL HHCCCEEEHHHHHHH | 22.68 | 26074081 | |
210 | Phosphorylation | SMAIHEVYQELIQDV HHHHHHHHHHHHHHH | 8.03 | 19060867 | |
222 | Phosphorylation | QDVLKQGYLWKRGHL HHHHHCCCCHHCCCC | 13.59 | - | |
225 | Acetylation | LKQGYLWKRGHLRRN HHCCCCHHCCCCCCC | 46.00 | 19608861 | |
256 | Ubiquitination | GSEECKEKRGIIPLD CCHHHHHHCCCCCCC | 41.23 | - | |
318 | Ubiquitination | IRLQAEGKTSLHKDL HHHHHCCCCCHHHHH | 26.84 | 29967540 | |
320 | Phosphorylation | LQAEGKTSLHKDLKQ HHHCCCCCHHHHHHH | 31.78 | 27067055 | |
323 | Ubiquitination | EGKTSLHKDLKQKRR CCCCCHHHHHHHHHH | 70.78 | 29967540 | |
343 | Ubiquitination | RERRRAAKEEELLRL HHHHHHHHHHHHHHH | 65.75 | - | |
357 | Ubiquitination | LQQLQEEKERKLQEL HHHHHHHHHHHHHHH | 63.17 | 24816145 | |
360 | Ubiquitination | LQEEKERKLQELELL HHHHHHHHHHHHHHH | 56.46 | 24816145 | |
387 | Phosphorylation | EEEERRRSQHRELQQ HHHHHHHHHHHHHHH | 28.64 | 28464451 | |
410 | Sulfoxidation | AEQARASMQAEMELK HHHHHHHHHHHHHHH | 4.23 | 21406390 | |
417 | Ubiquitination | MQAEMELKEEEAARQ HHHHHHHHHHHHHHH | 50.18 | 24816145 | |
429 | Ubiquitination | ARQRQRIKELEEMQQ HHHHHHHHHHHHHHH | 59.44 | 24816145 | |
434 | Sulfoxidation | RIKELEEMQQRLQEA HHHHHHHHHHHHHHH | 2.76 | 21406390 | |
491 | Ubiquitination | IERAQQEKEELQQEM HHHHHHHHHHHHHHH | 52.75 | 29967540 | |
498 | Sulfoxidation | KEELQQEMAQQSRSL HHHHHHHHHHHHHHH | 3.38 | 21406390 | |
504 | Phosphorylation | EMAQQSRSLQQAQQQ HHHHHHHHHHHHHHH | 35.46 | 24043423 | |
537 | Phosphorylation | QRKLRQASTNVKHWN HHHHHHHHHCCCHHH | 16.51 | - | |
538 | Phosphorylation | RKLRQASTNVKHWNV HHHHHHHHCCCHHHH | 47.23 | - | |
563 | Phosphorylation | PGDKRPVTSSSFSGF CCCCCCCCCCCCCCC | 26.10 | 30576142 | |
564 | Phosphorylation | GDKRPVTSSSFSGFQ CCCCCCCCCCCCCCC | 24.99 | 26074081 | |
565 | Phosphorylation | DKRPVTSSSFSGFQP CCCCCCCCCCCCCCC | 26.49 | 30576142 | |
566 | Phosphorylation | KRPVTSSSFSGFQPP CCCCCCCCCCCCCCC | 24.17 | 30576142 | |
568 | Phosphorylation | PVTSSSFSGFQPPLL CCCCCCCCCCCCCCC | 40.42 | 30576142 | |
580 | Phosphorylation | PLLAHRDSSLKRLTR CCCCCCCCHHHHHHH | 37.21 | 28993769 | |
581 | Phosphorylation | LLAHRDSSLKRLTRW CCCCCCCHHHHHHHH | 42.05 | 28993769 | |
586 | Phosphorylation | DSSLKRLTRWGSQGN CCHHHHHHHHCCCCC | 28.54 | 26074081 | |
590 | Phosphorylation | KRLTRWGSQGNRTPS HHHHHHCCCCCCCCC | 28.14 | 23401153 | |
595 | Phosphorylation | WGSQGNRTPSPNSNE HCCCCCCCCCCCCHH | 31.92 | 23401153 | |
597 | Phosphorylation | SQGNRTPSPNSNEQQ CCCCCCCCCCCHHHH | 35.78 | 23401153 | |
600 | Phosphorylation | NRTPSPNSNEQQKSL CCCCCCCCHHHHHHC | 45.16 | 23927012 | |
606 | Phosphorylation | NSNEQQKSLNGGDEA CCHHHHHHCCCCCCC | 23.80 | 28450419 | |
618 | Phosphorylation | DEAPAPASTPQEDKL CCCCCCCCCCCHHCC | 39.29 | 28450419 | |
619 | Phosphorylation | EAPAPASTPQEDKLD CCCCCCCCCCHHCCC | 30.97 | 28450419 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DEFI6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DEFI6_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-225, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-590 AND SER-597, ANDMASS SPECTROMETRY. |